2022 annual financial data
Jazz Pharmaceuticals 2022 Operating margin
Jazz Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -1.79%.
Operating income was -65,528,000 USD and net income was -224,060,000 USD.
Operating cash flow was 1,271,977,000 USD.
Get free Jazz Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,659,374,000 USD
- Operating income
- -65,528,000 USD
- Net income
- -224,060,000 USD
- Operating cash flow
- 1,271,977,000 USD